Literature DB >> 2320966

Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin.

H Peigue-Lafeuille1, N Gazuy, P Mignot, P Deteix, D Beytout, J C Baguet.   

Abstract

Respiratory syncytial virus (RSV) pneumonia may be a severe disease especially in immunocompromised patients. It is quite rare in adults. We report a case of severe RSV pneumonia in a 38-year-old male renal transplant recipient with successful outcome after ribavirin aerosol therapy.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2320966     DOI： 10.3109/00365549009023124

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  8 in total

1.  Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation.

Authors:  J T van Dissel; J M Zijlmans; A C Kroes; W E Fibbe
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

2.  Respiratory syncytial virus infections in pediatric renal transplant recipients.

Authors:  R B Miller; B M Chavers
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 3.  Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.

Authors:  M G Ottolini; V G Hemming
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

Review 5.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 6.  Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.

Authors:  Dana J Hawkinson; Michael G Ison
Journal:  Semin Nephrol       Date:  2016-09       Impact factor: 5.299

Review 7.  Community-acquired respiratory viruses.

Authors: 
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

Review 8.  Respiratory viral infections in immunocompetent and immunocompromised persons.

Authors:  R B Couch; J A Englund; E Whimbey
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.